-transparent.png){kind=logo}
Combined drug therapy with cholestyramine and compactin was found to be extremely effective against heterozygous cases of familial hypercholesterolemia. With a single drug regimen, compactin at a dosage of 15 mg/day produced a cholesterol reduction of 23% (70 mg/dl) in cases of combined hyperlipidemia, while twice the dosage (30 mg/day) was needed to produce a comparable effect with heterozygous familial hypercholesterolemia. When compaction was combined with cholestyramine (in a 4 g dose three times a day), the cholesterol-lowering effect of compactin was strongly improved with heterozygous familial hypercholesterolemia; half the dosage of compactin was enough to produce the additive effect compared with the effect produced by each single drug regimen.
A Yamamoto, and
T Yamamura, and
S Yokoyama, and
H Sudo, and
Y Matsuzawa
January 1980,
Artery,
A Yamamoto, and
T Yamamura, and
S Yokoyama, and
H Sudo, and
Y Matsuzawa
July 1990,
Anales espanoles de pediatria,
A Yamamoto, and
T Yamamura, and
S Yokoyama, and
H Sudo, and
Y Matsuzawa
January 1968,
Journal of atherosclerosis research,
A Yamamoto, and
T Yamamura, and
S Yokoyama, and
H Sudo, and
Y Matsuzawa
March 1983,
The New England journal of medicine,
A Yamamoto, and
T Yamamura, and
S Yokoyama, and
H Sudo, and
Y Matsuzawa
August 1992,
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
A Yamamoto, and
T Yamamura, and
S Yokoyama, and
H Sudo, and
Y Matsuzawa
July 1995,
The American journal of cardiology,
A Yamamoto, and
T Yamamura, and
S Yokoyama, and
H Sudo, and
Y Matsuzawa
January 1987,
Clinica chimica acta; international journal of clinical chemistry,
A Yamamoto, and
T Yamamura, and
S Yokoyama, and
H Sudo, and
Y Matsuzawa
January 2020,
Frontiers in pediatrics,
A Yamamoto, and
T Yamamura, and
S Yokoyama, and
H Sudo, and
Y Matsuzawa
January 1988,
JAMA,
A Yamamoto, and
T Yamamura, and
S Yokoyama, and
H Sudo, and
Y Matsuzawa
March 1977,
Pediatrics,
